Creabilis Appoints George F. Horner III as its Chairman
Creabilis SA announced the appointment of George F. Horner III as its Chairman. Mr Horner brings to Creabilis an unrivalled track record in building successful biotech businesses that have generated significant value for their shareholders.
Mr Horner has over 40 years industry experience gained with both biotech and big pharma companies. He was most recently the CEO of Prestwick Pharmaceuticals, a private CNS company that was sold to Biovail Corporation and Ovation Pharmaceuticals in late 2008. Prior to joining Prestwick, Mr Horner was the CEO of Vicuron, a publicly listed anti-infectives company that was sold to Pfizer for $1.9 billion in 2005. Mr Horner also worked for Ligand Pharmaceuticals following a successful career at Abbott Laboratories where his final position was as President of the company’s business in Canada. Mr Horner has also acted as an adviser to a number of specialist life science investors in recent years.
Other news from the department people
